← Back to Search

Brain Activity Monitoring for Parkinson's Disease Speech Impairment

N/A
Recruiting
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects scheduled for DBS implantation, as determined by the clinical multidisciplinary movement disorders board with definitive diagnosis of Parkinson's disease, essential tremor or dystonia.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of single dbs surgery
Awards & highlights

Study Summary

This trial is studying how the brain processes speech.

Who is the study for?
This trial is for adults aged 18-85 with Parkinson's disease, essential tremor, or dystonia who are scheduled for Deep Brain Stimulation (DBS) implantation. Participants must be able to understand the study and follow instructions. People with hearing loss or those who do not speak English cannot join.Check my eligibility
What is being tested?
The study aims to gather electrophysiological data on brain activity during speech perception and production in patients undergoing DBS surgery for movement disorders.See study design
What are the potential side effects?
Since this trial involves non-invasive data collection rather than a drug or medical intervention, there are no direct side effects associated with the procedures described.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for DBS implantation for Parkinson's, essential tremor, or dystonia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of single dbs surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of single dbs surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The number of subjects providing the interpretable speech related electrophysiological data collection.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Brain signal data collectionExperimental Treatment1 Intervention
Brain signal data collection at the time of deep brain stimulation (DBS) surgery.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,933 Previous Clinical Trials
13,198,421 Total Patients Enrolled

Media Library

electrophysiological data collection Clinical Trial Eligibility Overview. Trial Name: NCT04286308 — N/A
Parkinson's Disease Research Study Groups: Brain signal data collection
Parkinson's Disease Clinical Trial 2023: electrophysiological data collection Highlights & Side Effects. Trial Name: NCT04286308 — N/A
electrophysiological data collection 2023 Treatment Timeline for Medical Study. Trial Name: NCT04286308 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment phase for this experiment still open?

"Available data from clinicaltrials.gov indicates that at present, this research project is looking for participants to enrol. The study was initially posted on the 1st of October 2020 and its most recent update occurred on the 11th of November 2022."

Answered by AI

What is the scope of individuals participating in this clinical trial?

"Affirmative. The clinical trial is searching for applicants and the information on clinicaltrials.gov confirms this, noting that it was first posted on October 1st 2020 and last modified November 11th 2022. Eighty individuals need to be enrolled from a single location."

Answered by AI

What are the qualifications necessary to partake in this medical experiment?

"The eligibility criteria for this clinical trial demands that candidates suffer from dystonia and fall in the 18-85 year old age range. Around 80 people will be accepted into the program."

Answered by AI

Does this clinical trial accept participants ages 25 and above?

"In order to be eligible for this medical trial, patients must fall between 18 and 85 years of age. Conversely, there are 28 studies dedicated to minors under the age of 18 as well as 533 trials targeting those over 65."

Answered by AI
~14 spots leftby Feb 2025